Houston, Texas 77030


This trial studies how well a mobile smartphone application called Quitting Schedule works in helping participants to quit smoking. Quitting Schedule is based on WebCASSI, a computer-based initiative that offered state of-the-art smoking cessation treatment and counseling to MD Anderson Cancer Center (MDACC) patients and served as a portal for non-patients to find information regarding smoking cessation advice and treatments. Quitting Schedule may help participants to quit smoking.

Study summary:

PRIMARY OBJECTIVES: I. To adapt the internal algorithms of the scheduled reduced smoking approach in Computer Assisted Stop Smoking Intervention for the World Wide Web (WebCASSI) into a smartphone application (app): Quitting Schedule. II. Once the smartphone app is developed, a pretesting phase with smoker seeking care at MDACC Tobacco Treatment Program or another community service such as Equality Texas, Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) Advisory Board of the City of Houston, Montrose Center, Avenue 360 and Lesbian Health Initiative will follow. III. To culturally and linguistically adapt Quitting Schedule app into Spanish language. IV. To implement a feasibility trial in IDC (Colombia), INCan (Mexico), and INEN (Peru). OUTLINE: AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule. AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.


Inclusion Criteria: - Current smokers (those who smoke at least 5 cigarettes a day; confirmed with carbon monoxide (CO) levels equal or above 7 parts per million) newly enrolled in the Tobacco Treatment Program at MDACC. (Aim 2) - Adult cancer patients. (Aim 2) - Current smokers seeking care at the Tobacco Treatment Program at MD Anderson and at Houston area community services who have smoked at least 100 cigarettes in lifetime. - Willing to download and use the app Quitting Schedule. (Aim 2) - Willing to set a quit smoking date within 5 weeks of the enrollment. (Aim 2) - Ownership of an iPhone or Android smartphone. (Aim 2) Exclusion Criteria: - Unwillingness to participate in the study. (Aim 2) - Enrolled in another cessation program. (Aim 2) - Current use of nicotine replacement (NRT) or other smoking cessation medications, e.g. varenicline or bupropion outside of the MD Anderson Institution. (Aim 2) - Expired CO levels below 7 parts per million (ppm). (Aim 2)



Primary Contact:

Principal Investigator
Paul Cinciripini
M.D. Anderson Cancer Center

Paul Cinciripini
Phone: 713-563-1264
Email: pcinciri@mdanderson.org

Backup Contact:


Location Contact:

Houston, Texas 77030
United States

Paul Cinciripini
Phone: 713-563-1264

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.